Contract 36C25023D0083
Guardian Pharmacy Of Indianapolis Nuclear, Llc · Department Of Veterans Affairs · September 29, 2023
Guardian Pharmacy Of Indianapolis Nuclear, Llc was awarded a federal contract by Department Of Veterans Affairs on September 29, 2023 for an undisclosed amount of work in pharmaceutical preparation manufacturing. It was awarded under full and open competition. The contract has been modified 2 times since the base award It uses firm fixed-price contract pricing. The most recent modification was on April 1, 2026. If all options are exercised, the contract could reach $2.00 million.
Contract details
- PIID
- 36C25023D0083
- Award type
- —
- Pricing
- Firm Fixed Price
- Set-aside
- No Set Aside Used.
- Competition
- Full And Open Competition
- NAICS
- 325412 · Pharmaceutical Preparation Manufacturing
- Product / service
- Drugs And Biologicals
- First action
- September 29, 2023
- Latest action
- April 1, 2026
Description
5 YEAR FOR VARIOUS RADIO PHARMACEUTICALS
Modification timeline
-
April 1, 2026Mod P00004 · Supplemental Agreement For Work Within Scope$0
-
March 26, 2026Mod P00003 · Supplemental Agreement For Work Within Scope$0
-
September 29, 2023Base award$0
Similar contracts
| Recipient | Agency | Date | Obligated |
|---|---|---|---|
| Petnet Solutions, Inc. | Department Of Veterans Affairs | April 1, 2026 | $387.4K |
| Eli Lilly And Company | Department Of Veterans Affairs | April 1, 2026 | $0 |
| Exelan Pharmaceuticals Inc | Department Of Veterans Affairs | April 1, 2026 | $0 |
| Cardinal Health 414, Llc | Department Of Veterans Affairs | April 1, 2026 | $122.9K |
| Jubilant Draximage Inc | Department Of Veterans Affairs | April 1, 2026 | $0 |
| Cardinal Health 414, Llc | Department Of Veterans Affairs | April 1, 2026 | $184.3K |
Top contractors in NAICS 325412
Lifetime obligated dollars across all federal contracts in this NAICS code.
| # | Contractor | Contracts | Obligated |
|---|---|---|---|
| 1 | Mckesson Corporation | 1,187 | $4.96B |
| 2 | Merck Sharp & Dohme Llc | 26 | $894.71M |
| 3 | Sanofi Vaccines Us Inc. | 57 | $702.38M |
| 4 | Pfizer Inc | 169 | $541.15M |
| 5 | Glaxosmithkline, Llc | 14 | $505.04M |
| 6 | Phlow Corp. | 1 | $105.27M |
| 7 | Exelan Pharmaceuticals Inc | 76 | $104.30M |
| 8 | Seqirus USA Inc | 47 | $59.15M |
| 9 | Emergent Biosolutions Canada Inc | 2 | $53.73M |
| 10 | Mckesson Specialty Distribution Llc | 1 | $51.05M |
Track this on BesaGov
Get a free weekly email when this changes — new awards, new sub-awards, new opportunities. No login required.
Continue learning
Keep researching
Frequently asked questions
What is contract 36C25023D0083?
Contract 36C25023D0083 is a federal contract awarded to Guardian Pharmacy Of Indianapolis Nuclear, Llc by Department Of Veterans Affairs on September 29, 2023 for an undisclosed amount of work classified under PHARMACEUTICAL PREPARATION MANUFACTURING. It has been modified 2 times since the base award.
Who won contract 36C25023D0083?
Guardian Pharmacy Of Indianapolis Nuclear, Llc won contract 36C25023D0083 from Department Of Veterans Affairs.
How much is contract 36C25023D0083 worth?
Contract 36C25023D0083 has obligated $0 to date but carries a potential ceiling of $2.00 million if fully funded and all options are exercised.